MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

2007331 citationsJournal Article

Authors

Natalizumab has a sustained effect in preventing the formation of new lesions in patients with relapsing multiple sclerosis.

Good health and well-being

Published in: Neurology

Volume 68, Issue 17, pp. 1390-1401

Field-Weighted Citation Impact: 11.55